Renal Denervation in 2025: What the Latest Data, Guideline and NCD Mean for Your Practice
Renal denervation (RDN) is rapidly advancing as an evidence-based intervention for hypertension, supported by updated international guidelines and an expanding body of long-term clinical data. In this on-demand programme, viewers will gain expert-driven insights into the latest recommendations and clinical evidence, with emphasis on how these developments translate into everyday patient care.
Through focused discussions and real-world case examples, the faculty, led and moderated by Dr Sripal Bangalore (New York University Langone Medical Center, New York, US), explores key topics including patient selection, procedural best practices and post-procedural outcomes. The session highlights practical strategies for integrating RDN into contemporary treatment pathways.
Your feedback helps us improve medical education and measure impact on clinical practice.
Learning Objectives
- Describe guideline recommendations for renal denervation (RDN)
- Recall recent clinical trial data and real-world evidence for RDN
- Apply an evidence-based approach to patient selection for RDN
- Use expert experience to optimise RDN therapy in real-world practice
Target Audience
- Cardiologists
- Interventionalists
- Hypertension Specialists
More from this programme
Part 1
Dr Sripal Bangalore introduces the session and the panel.
| 1 session | |
| Introduction - Dr Sripal Bangalore | Watch now |
Part 2
Dr Kirtane reviews uRDN technology and emerging TCT data, including European real-world GPS results and a pooled 24-month analysis, then explores how these findings address guideline gaps, inform clinical decision-making and shape evolving practice for hypertension management in contemporary care.
| 1 session | |
| Integrating Emerging Data from TCT | Watch now |
Part 3
Dr Tehrani highlights real-world uRDN experience, featuring a brief centre presentation followed by a broad faculty discussion on practical use, patient selection, follow-up approaches, reimbursement considerations and perspectives on the future role of uRDN in everyday clinical practice.
| 1 session | |
| Real-World Experiences | Watch now |
Part 4
Dr Laffin reviews the 2025 AHA/ACC hypertension guideline updates on RDN, comparing US recommendations with 2023–2024 European guidance and explores expert perspectives on ideal patient populations, including BP thresholds, medication intolerance, background therapy and considerations for high-risk individuals.
Part 5
This closing segment features a live audience Q&A followed by Dr Bangalore's summary on the key insights from the webinar, reinforcing practical takeaways for applying emerging evidence and guideline updates in contemporary hypertension care.
| 1 session | |
| Audience Q&A & Closing Remarks | Watch now |
Faculty Biographies
Sripal Bangalore
Dr Sripal Bangalore is an Interventional Cardiologist and a Professor of Medicine with tenure at New York University School of Medicine. He is the Director of Invasive and Interventional Cardiology, Director of Complex Coronary Intervention and Interventional Director, Adult ECMO, MCS and PERT Program at Bellevue Hospital; Director of Research for the cardiac catheterisation laboratory at NYU Langone Medical Center. His clinical expertise is in complex coronary intervention including CTOs, ultra low volume/zero contrast PCI, mechanical circulatory support and PERT. His research interests are in comparative effectiveness studies for stable ischemic heart disease, acute coronary syndromes, and hypertension. He is on writing committee for the ACC/AHA/SCAI revascularisation guidelines.
Ajay J Kirtane
Professor of Clinical Medicine
Ajay J Kirtane, is Professor of Medicine at the Columbia University Medical Center (CUMC) and Director of the Cardiac Catheterization Laboratories at NewYork-Presbyterian (NYP) Hospital / CUMC. Dr. Kirtane is an internationally-renowned leader in Interventional Cardiology, specializing in the care of patients with complex coronary and peripheral vascular disease.
In addition to his clinical commitments, Ajay has a strong interest in clinical education and research, serving as Chief Academic Officer of Columbia Interventional Cardiovascular Care. He is a director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics conference, has served as a director of several international, national, and regional educational conferences, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Ajay’s research…
Behnam Tehrani
Dr Behnam Tehrani is a System Associate Director for Interventional Cardiology, Executive Director of the Cardiac Catheterization Laboratories for Inova and Co-Director of Complex Coronary Therapeutic Program.
Dr Behnam Tehrani also serves as an assistant clinical professor of medicine at both George Washington University and the University of Virginia. He is involved in clinical trials and registries pertaining to complex coronary interventions, renal denervation, cardiogenic shock and pulmonary embolism.
Dr Tehrani is also part of the team that introduced renal denervation services for treating resistant hypertension, as well as the rapid-response team for diagnosing and treating pulmonary embolism and the team that treats chronic thromboembolic pulmonary hypertension.
Recognised nationally for his leadership, Dr Tehrani serves on committees for both the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions. He has co…
Luke Laffin
Preventive Cardiologist
Dr Luke Laffin is a physician in the Preventive Cardiology & Rehabilitation Section in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute. He sees patients at Cleveland Clinic main campus and is the medical director of cardiac rehabilitation. Specialty Interests: Cardiology, preventive cardiology, hypertension (high blood pressure), resistant hypertension, refractory hypertension, cardiovascular risk factor assessment and modification, coronary artery disease, labile blood pressure, ambulatory blood pressure monitoring, home blood pressure monitoring Education: Dr. Laffin earned his medical degree from Vanderbilt University School of Medicine, Nashville, Tenn. He served his residency at University of Chicago Medical Center, Chicago, Ill., followed by fellowships in hypertensive diseases and cardiovascular disease there. He was named to the Cleveland Clinic staff in 2018.